...
首页> 外文期刊>Cureus. >D-Dimer: A Potential Solution to Problems of Cancer Screening, Surveillance, and Prognosis Assessment
【24h】

D-Dimer: A Potential Solution to Problems of Cancer Screening, Surveillance, and Prognosis Assessment

机译:D-DIMOR:对癌症筛查,监测和预后评估问题的潜在解决方案

获取原文
           

摘要

Research has established a direct link between the plasma level of D-dimer and underlying malignancy. D-dimer has a strong association with the detection and prognosis of several cancers. For these reasons, this literature review aimed to evaluate the usefulness of elevated D-dimer levels in the initial screening of cancer, cancer recurrence surveillance, and for use as a cancer prognostic tool. A search of PubMed up to February 1, 2021, was carried out by reviewers. This literature review includes studies investigating the relationship between pretreatment plasma D-dimer levels and cancer. From the findings, pretreatment D-dimer levels can assist with cancer screening and prognosis assessment. Pretreatment plasma D-dimer levels can function as an effective cancer recurrence control. Elevated pre-treatment plasma D-dimer concentration is valuable in facilitating cancer screening, predicting an augmented risk of cancer recurrence, and anticipating a worse cancer prognosis.
机译:研究建立了D-二聚体等血浆水平与潜在恶性肿瘤之间的直接联系。 D-DIMER具有强大的关联与几种癌症的检测和预后。 由于这些原因,该文献综述旨在评估癌症,癌症复发监测和用作癌症预后工具的初始筛查中升高的D-二聚体水平的有用性。 在审稿人员开展了高达2021年2月1日的Pubmed搜索。 该文献综述包括研究预处理血浆D-二聚体水平和癌症之间关系的研究。 从调查结果中,预处理D-二聚体水平可以有助于癌症筛查和预后评估。 预处理等离子体D-二聚体水平可以作为有效的癌症复发控制。 升高的预处理等离子体D-二聚体浓度在促进癌症筛查方面有价值,预测癌症复发的增强风险,并期望更糟糕的癌症预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号